Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

537

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

537 results for “Pharmaceuticals”

Learn how ShareScore rates datasets ↗
zenodo24/100

Figure 1 from: Golembiovska О, Voskoboinik O, Berest G, Kovalenko S, Logoyda L (2021) Quality by design approach for simultaneous determination of original active pharmaceutical ingredient quinabut and its impurities by using HPLC. Message 1. Pharmacia 68(1): 79-87. https://doi.org/10.3897/pharmacia.68.e50704

Figure 1 Chemical structures of quinabut (I) and impurity A (II).

opencc-by-4.0Jan 2021View details →
zenodo24/100

Figure 1 from: Todorova A, Ivanova M, Petkova V (2024) Pharmacists' burnout and motivation for pharmaceutical care in chronically ill patients - a pilot study for the north-eastern region of Bulgaria. Pharmacia 71: 1-7. https://doi.org/10.3897/pharmacia.71.e120566

Figure 1 Difficulties dispensing prescriptions for chronically ill patients paid by the NHIF.

opencc-by-4.0Mar 2024View details →
zenodo24/100

Figure 4 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559

Figure 4 Absorption spectra of BPB and valsartan with BPB in different solvents.

opencc-by-4.0Nov 2021View details →
zenodo24/100

Figure 6 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559

Figure 6 Absorption spectra of MR and valsartan with MR in different solvents.

opencc-by-4.0Nov 2021View details →
zenodo24/100

Figure 2 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559

Figure 2 Absorption spectra of valsartan with BPB

opencc-by-4.0Nov 2021View details →
zenodo24/100

Figure 3 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559

Figure 3 Absorption spectra of valsartan with MR.

opencc-by-4.0Nov 2021View details →
zenodo24/100

Figure 1 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559

Figure 1 Chemical structure of valsartan.

opencc-by-4.0Nov 2021View details →
zenodo24/100

Figure 10 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559

Figure 10 Calibration curve for the determination of valsartan with BPB.

opencc-by-4.0Nov 2021View details →
zenodo24/100

Figure 11 from: Peleshok K, Bondar B, Kryskiw L, Kucher T, Poliak O, Logoyda L (2021) Non-extractive spectrophotometric determination of valsartan in pure form and in pharmaceutical products by ion-pair complex formation with bromophenol blue and methyl red. Pharmacia 68(4): 851-858. https://doi.org/10.3897/pharmacia.68.e73559

Figure 11 Calibration curve for the determination of valsartan with MR.

opencc-by-4.0Nov 2021View details →
zenodo24/100

Figure 2 from: Stoimenova A, Kirilov B, Zaykova K (2019) Analysis of good distribution practice inspection deficiency data of pharmaceutical wholesalers in Bulgaria. Pharmacia 66(3): 85-89. https://doi.org/10.3897/pharmacia.66.e35880

Figure 2 No of suspended wholesale authorizations 2009–2018.

opencc-by-4.0Mar 2022View details →
zenodo24/100

Figure 1 from: Stoimenova A, Kirilov B, Zaykova K (2019) Analysis of good distribution practice inspection deficiency data of pharmaceutical wholesalers in Bulgaria. Pharmacia 66(3): 85-89. https://doi.org/10.3897/pharmacia.66.e35880

Figure 1 Number of authorizations issued 2007–2018.

opencc-by-4.0Mar 2022View details →
zenodo24/100

Predicting the solvation of organic compounds in aqueous environments: from alkanes and alcohols to pharmaceuticals

<p>Please refer to the article entitled "Predicting the solvation of organic compounds in aqueous environments: from alkanes and alcohols to pharmaceuticals" for full detail.</p>

opencc-by-4.0Jul 2017View details →
zenodo24/100

Supplementary Material for 'Generation Z Doctors' Preferences Towards Pharmaceutical Marketing': Survey Instrument and Response Distribution

<p>This supplementary material accompanies the study 'Generation Z Doctors and the Future of Pharma Marketing in India.' It includes the complete survey instrument used to gather insights from Generation Z doctors, as well as detailed response distribution tables. The material provides additional data that supports the quantitative and qualitative analyses presented in the main manuscript, offering a comprehensive understanding of the engagement preferences, decision-making paradigms, and ethical considerations influencing Generation Z doctors' interactions with pharmaceutical marketing. This dataset is intended to facilitate further research and enhance the transparency of the study's findings.</p>

opencc-by-4.0Oct 2024View details →
zenodo24/100

Figure 2 from: Ivanova V, Pavlov D, Assenova T, Terzieva E, Milushewa P, Djemadan A, Vladimirova G, Dimitrova M, Kamusheva M (2021) COVID-19 pandemic impact on the pharmaceutical sector in Bulgaria. Pharmacia 68(3): 713-720. https://doi.org/10.3897/pharmacia.68.e71638

Figure 2 Sectors negatively affected by COVID-19.

opencc-by-4.0Sep 2021View details →
zenodo24/100

Figure 3 from: Ivanova V, Pavlov D, Assenova T, Terzieva E, Milushewa P, Djemadan A, Vladimirova G, Dimitrova M, Kamusheva M (2021) COVID-19 pandemic impact on the pharmaceutical sector in Bulgaria. Pharmacia 68(3): 713-720. https://doi.org/10.3897/pharmacia.68.e71638

Figure 3 Sectors positively affected by COVID-19.

opencc-by-4.0Sep 2021View details →
zenodo24/100

Figure 1 from: Ivanova V, Pavlov D, Assenova T, Terzieva E, Milushewa P, Djemadan A, Vladimirova G, Dimitrova M, Kamusheva M (2021) COVID-19 pandemic impact on the pharmaceutical sector in Bulgaria. Pharmacia 68(3): 713-720. https://doi.org/10.3897/pharmacia.68.e71638

Figure 1 Work flow changes in pharmaceutical companies due to COVID-19.

opencc-by-4.0Sep 2021View details →
zenodo24/100

Figure 4 from: Ivanova V, Pavlov D, Assenova T, Terzieva E, Milushewa P, Djemadan A, Vladimirova G, Dimitrova M, Kamusheva M (2021) COVID-19 pandemic impact on the pharmaceutical sector in Bulgaria. Pharmacia 68(3): 713-720. https://doi.org/10.3897/pharmacia.68.e71638

Figure 4 Influence of COVID-19 on the pharmaceutical industry in Bulgaria.

opencc-by-4.0Sep 2021View details →
ClinicalTrials.gov24/100

Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose)

ClinicalTrials.gov study NCT02534480. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Effectiveness of Pharmaceutical Care on Primary Care Patients With Uncontrolled Hypertension

ClinicalTrials.gov study NCT00807131. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable Tablets 5mg Under Fasted Conditions

ClinicalTrials.gov study NCT01931501. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record